Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury

Inclusion criteria

• Patient who don't have any possiblity of improving neurological function despite performed the optimal treatment after spinal cord injury
• No change in neurological function for 4weeks interval by at least 2 clincal medical specialists
• Patient who is able to give written informed consent of clinical trial about stemcells treatment

Exclusion criteria

• Patient who is under 19 years and over 70years
• Patient who must use the mechanical ventilator
• Patient who have a history of malignant tumor within 5 years
• Patient who is having a infectious disease of including current hepatitis and HIV
• Patient who had the brain or spinal cord injury before the spinal cord injury (confirm subject's history from their medical history)
• Patient who is having a acute disease judged by principle investigator or having a fever over 38.0 ℃ at the vaccination day
• Patient who is having an anemia or thrombopenia
• Patient who is having an angina, myocardial infarct, myocardiopathy, obstructive vessel disease, chronic renal failure, glomerulopathy and chronic obstruent lung disease (confirm subject's history from their medical history)
• Patient who is having a Congenital Immune Deficiency Syndrome or AIDS (confirm subject's history from their medical history)
• Patient who is having an amyotrophia or joint atrophy
• Patient who is having an disturbanace of consciousness or dysphrasia
• Patient who is taking an immunosuppressive agents or corticosteroids agents or cytotoxic agents or needed administration
• Patient who have experienced another clinical trials within 3 months involving this clinical trial
• Patient who can't participate in this clinical trial having any opinion regarded as clinical significance judged by principle investigator